Partner Clinics

The technology for the pancreatic cancer blood test has been exclusively licensed to YD Biopharma, which holds full rights for its commercial development, marketing, and distribution.

YD Biopharma is committed to delivering high-quality service in the U.S. market. If you are considered high risk for pancreatic cancer, we encourage you to schedule a consultation with Myrostar Health to determine if this test is appropriate for you.